首页 > 最新文献

Journal of Current Ophthalmology最新文献

英文 中文
Posterior Microphthalmos Pigmentary Retinopathy Syndrome with Angle-Closure Glaucoma: A Case Report. 后小眼色素视网膜病变综合征合并闭角型青光眼1例。
IF 1.5 Q2 Medicine Pub Date : 2022-10-01 DOI: 10.4103/joco.joco_145_22
Hela Sassi, Khaled Ammar, Meriem Ouederni, Monia Cheour

Purpose: To describe a particular form of posterior microphthalmos pigmentary retinopathy syndrome (PMPRS) with an atypical clinical presentation of pigment retinal dystrophy and an association to an inconstant complication which is angle-closure glaucoma (ACG).

Methods: A 40-year-old male patient with ACG on maximal topical treatment was referred to our department for uncontrolled intraocular pressure. Best-corrected visual acuity was 2/10 in the right eye and light perception in the left eye. Intraocular pressure was 36 mmHg bilaterally. He had 360° peripheral anterior synechiae on gonioscopy. Fundus examination revealed total cupping with pale retinal lesions in both eyes and a few pigment deposits in the midperiphery of the right eye. Multimodal imaging was done.

Results: Fundus autofluorescence revealed patchy areas of hypoautofluorescence. Optical coherence tomography (OCT) showed bilateral foveoschisis and macular folds. Anterior segment OCT showed a circumferential iridocorneal angle closure. Axial length measured with ultrasound biomicroscopy was 18.4 mm in the right eye and 18.1 in the left eye. Electroretinogram revealed attenuated scotopic responses. The patient was diagnosed with nanophthalmos-retinitis pigmentosa (RP)-foveoschisis syndrome complicated with ACG. A combined surgery with phacoemulsification - anterior vitrectomy - intraocular lens implantation and trabeculectomy was performed in both eyes with a satisfactory outcome.

Conclusions: In its typical forms, PMPR syndrome is an association of nanophthalmos - RP - foveoschisis and optic nerve head (ONH) drusen. Incomplete phenotypes may lack ONH drusen or foveoschisis. Patients with PMPRS have to be screened for iridocorneal angle synechia and ACG.

目的:描述一种特殊形式的后小眼色素性视网膜病变综合征(PMPRS),其非典型临床表现为色素视网膜营养不良,并与闭角型青光眼(ACG)的不稳定并发症有关。方法:1例40岁男性ACG患者因眼压不控制而接受最大局部治疗。右眼最佳矫正视力为2/10,左眼最佳矫正视力为光感。双侧眼压36mmhg。他有360°周围前粘连的角镜检查。眼底检查显示全火罐,双眼视网膜病变苍白,右眼中周少量色素沉积。进行多模态成像。结果:眼底自身荧光显示斑片状的低自身荧光区。光学相干断层扫描(OCT)显示双侧凹裂和黄斑褶皱。前段OCT显示环虹膜角膜角闭合。超声生物显微镜测得的眼轴长为右眼18.4 mm,左眼18.1 mm。视网膜电图显示暗斑反应减弱。患者被诊断为视网膜色素变性(RP)-视网膜凹裂综合征合并ACG。双眼行超声乳化术-前眼玻璃体切除术-人工晶状体植入术及小梁切除术,手术效果满意。结论:PMPR综合征的典型表现为纳米眼- RP -中心凹裂和视神经头(ONH)水肿。不完整的表型可能缺乏ONH结节或凹裂。PMPRS患者必须筛查虹膜-角膜角粘连和ACG。
{"title":"Posterior Microphthalmos Pigmentary Retinopathy Syndrome with Angle-Closure Glaucoma: A Case Report.","authors":"Hela Sassi,&nbsp;Khaled Ammar,&nbsp;Meriem Ouederni,&nbsp;Monia Cheour","doi":"10.4103/joco.joco_145_22","DOIUrl":"https://doi.org/10.4103/joco.joco_145_22","url":null,"abstract":"<p><strong>Purpose: </strong>To describe a particular form of posterior microphthalmos pigmentary retinopathy syndrome (PMPRS) with an atypical clinical presentation of pigment retinal dystrophy and an association to an inconstant complication which is angle-closure glaucoma (ACG).</p><p><strong>Methods: </strong>A 40-year-old male patient with ACG on maximal topical treatment was referred to our department for uncontrolled intraocular pressure. Best-corrected visual acuity was 2/10 in the right eye and light perception in the left eye. Intraocular pressure was 36 mmHg bilaterally. He had 360° peripheral anterior synechiae on gonioscopy. Fundus examination revealed total cupping with pale retinal lesions in both eyes and a few pigment deposits in the midperiphery of the right eye. Multimodal imaging was done.</p><p><strong>Results: </strong>Fundus autofluorescence revealed patchy areas of hypoautofluorescence. Optical coherence tomography (OCT) showed bilateral foveoschisis and macular folds. Anterior segment OCT showed a circumferential iridocorneal angle closure. Axial length measured with ultrasound biomicroscopy was 18.4 mm in the right eye and 18.1 in the left eye. Electroretinogram revealed attenuated scotopic responses. The patient was diagnosed with nanophthalmos-retinitis pigmentosa (RP)-foveoschisis syndrome complicated with ACG. A combined surgery with phacoemulsification - anterior vitrectomy - intraocular lens implantation and trabeculectomy was performed in both eyes with a satisfactory outcome.</p><p><strong>Conclusions: </strong>In its typical forms, PMPR syndrome is an association of nanophthalmos - RP - foveoschisis and optic nerve head (ONH) drusen. Incomplete phenotypes may lack ONH drusen or foveoschisis. Patients with PMPRS have to be screened for iridocorneal angle synechia and ACG.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/92/90/JCO-34-474.PMC10170979.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10662701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bilateral Acute Iris Transillumination without Prior Systemic Antibiotics. 双侧急性虹膜透光术,未使用全身抗生素。
IF 1.5 Q2 Medicine Pub Date : 2022-10-01 DOI: 10.4103/joco.joco_93_22
Mohamed F Oraby, Salah Aldin Alrashidi, Sherein Mahmoud Hagras

Purpose: To describe a case of bilateral acute iris transillumination (BAIT) with no history of systemic infections or antibiotics intake before the attack.

Methods: This study included the review of the clinical record of the patient.

Results: A 29-year-old male was referred to the glaucoma clinic with presumed bilateral acute iridocyclitis with refractory glaucoma. Ophthalmic examination revealed bilateral pigment dispersion, marked iris transillumination, dense pigment deposition in the iridocorneal angle, and high intraocular pressure. The patient was diagnosed with BAIT and was followed for 5 months.

Conclusion: The diagnosis of BAIT can be elicited even without a prior history of systemic infection or antibiotics intake.

目的:报告1例双侧急性虹膜透光(BAIT),发作前无全身性感染或抗生素摄入史。方法:本研究包括回顾患者的临床记录。结果:一名29岁男性患者因双侧急性虹膜睫状体炎合并难治性青光眼被转诊至青光眼诊所。眼科检查发现双侧色素分散,虹膜透光明显,虹膜-角膜角密集色素沉积,眼压高。确诊为乙型肝炎,随访5个月。结论:即使没有全身性感染或抗生素摄入史,也可以诊断出乙型肝炎。
{"title":"Bilateral Acute Iris Transillumination without Prior Systemic Antibiotics.","authors":"Mohamed F Oraby,&nbsp;Salah Aldin Alrashidi,&nbsp;Sherein Mahmoud Hagras","doi":"10.4103/joco.joco_93_22","DOIUrl":"https://doi.org/10.4103/joco.joco_93_22","url":null,"abstract":"<p><strong>Purpose: </strong>To describe a case of bilateral acute iris transillumination (BAIT) with no history of systemic infections or antibiotics intake before the attack.</p><p><strong>Methods: </strong>This study included the review of the clinical record of the patient.</p><p><strong>Results: </strong>A 29-year-old male was referred to the glaucoma clinic with presumed bilateral acute iridocyclitis with refractory glaucoma. Ophthalmic examination revealed bilateral pigment dispersion, marked iris transillumination, dense pigment deposition in the iridocorneal angle, and high intraocular pressure. The patient was diagnosed with BAIT and was followed for 5 months.</p><p><strong>Conclusion: </strong>The diagnosis of BAIT can be elicited even without a prior history of systemic infection or antibiotics intake.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/91/10/JCO-34-469.PMC10170978.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9822301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of the Sedative, Hemodynamic, and Anesthetic Effect of Dexmedetomidine, Ketamine, and Etomidate on Cataract Surgery by Phacoemulsification Method: A Randomized Clinical Trial. 右美托咪定、氯胺酮和依托咪酯在白内障超声乳化手术中的镇静、血流动力学和麻醉效果的比较:一项随机临床试验。
IF 1.5 Q2 Medicine Pub Date : 2022-10-01 DOI: 10.4103/joco.joco_158_22
Bardia Moghisseh, Hesameddin Modir, Esmail Moshiri, Zahra Motaghinia, Mohammadreza Bozorgmanesh

Purpose: To compare dexmedetomidine, ketamine, and etomidate in the induction of sedation and hemodynamic changes in patients undergoing cataract surgery by phacoemulsification method.

Methods: This was a double-blind clinical trial study carried out on 128 patients. Using the block randomization method, the patients were divided into four equal groups (dexmedetomidine, ketamine, etomidate, and control). Mean arterial pressure, heart rate, and arterial oxygen saturation, Ramsay Sedation Score were recorded every 5 min intraoperatively, in recovery, and 1, 2, 4, and 6 h postoperatively. Moreover, the Aldrete score was measured in recovery time for discharge from the recovery room.

Results: The mean age of participants was found to be 63.16 ± 6.07 years, and there was no statistically significant difference between the groups in terms of age, sex, and body mass index, SpO2, and heart rate (P > 0.05). From 15 min after the start of surgery to 6 h postoperatively, the mean arterial pressure in the dexmedetomidine group was significantly lower than that in the other three groups, including ketamine, etomidate, and control (P < 0.05). The mean sedation score (Ramsay) during recovery and 1 h postoperatively was higher in the dexmedetomidine group compared with that in the control group, whereas the recovery time in the dexmedetomidine group was higher than that in the other groups (P < 0.001). In addition, the amount of propofol consumption in the two groups of dexmedetomidine and ketamine was significantly less than that in the etomidate and control groups (P < 0.001).

Conclusions: According to the results, dexmedetomidine caused better hemodynamic changes with more reduction in blood pressure and heart rate, and patients in the dexmedetomidine group did not require any specific medical treatment. Moreover, higher patient satisfaction and longer recovery duration were observed in the dexmedetomidine group than in the other study groups. As such, it is suggested that dexmedetomidine be used as an adjuvant in cataract surgery for more sedation, analgesia, and optimal intraoperative conditions.

目的:比较右美托咪定、氯胺酮和依托咪酯对超声乳化白内障手术患者镇静和血流动力学改变的诱导作用。方法:对128例患者进行双盲临床研究。采用分组随机法,将患者分为4组(右美托咪定、氯胺酮、依托咪酯和对照组)。术中、恢复时及术后1、2、4、6 h每5 min记录一次平均动脉压、心率、动脉血氧饱和度、Ramsay镇静评分。此外,从恢复室出院的恢复时间测量Aldrete评分。结果:参与者平均年龄为63.16±6.07岁,年龄、性别、体质量指数、SpO2、心率组间差异无统计学意义(P > 0.05)。手术开始后15 min至术后6 h,右美托咪定组平均动脉压显著低于氯胺酮、依托咪酯和对照组(P < 0.05)。右美托咪定组恢复期和术后1 h平均镇静评分(Ramsay)高于对照组,恢复时间显著高于其他组(P < 0.001)。此外,右美托咪定和氯胺酮两组患者异丙酚用量显著低于依托咪酯组和对照组(P < 0.001)。结论:结果显示,右美托咪定对血流动力学的影响较好,血压和心率下降幅度更大,且右美托咪定组患者不需要任何特殊的药物治疗。此外,与其他研究组相比,右美托咪定组患者满意度更高,恢复时间更长。因此,建议在白内障手术中使用右美托咪定作为辅助剂,以获得更多的镇静、镇痛和最佳的术中条件。
{"title":"Comparison of the Sedative, Hemodynamic, and Anesthetic Effect of Dexmedetomidine, Ketamine, and Etomidate on Cataract Surgery by Phacoemulsification Method: A Randomized Clinical Trial.","authors":"Bardia Moghisseh,&nbsp;Hesameddin Modir,&nbsp;Esmail Moshiri,&nbsp;Zahra Motaghinia,&nbsp;Mohammadreza Bozorgmanesh","doi":"10.4103/joco.joco_158_22","DOIUrl":"https://doi.org/10.4103/joco.joco_158_22","url":null,"abstract":"<p><strong>Purpose: </strong>To compare dexmedetomidine, ketamine, and etomidate in the induction of sedation and hemodynamic changes in patients undergoing cataract surgery by phacoemulsification method.</p><p><strong>Methods: </strong>This was a double-blind clinical trial study carried out on 128 patients. Using the block randomization method, the patients were divided into four equal groups (dexmedetomidine, ketamine, etomidate, and control). Mean arterial pressure, heart rate, and arterial oxygen saturation, Ramsay Sedation Score were recorded every 5 min intraoperatively, in recovery, and 1, 2, 4, and 6 h postoperatively. Moreover, the Aldrete score was measured in recovery time for discharge from the recovery room.</p><p><strong>Results: </strong>The mean age of participants was found to be 63.16 ± 6.07 years, and there was no statistically significant difference between the groups in terms of age, sex, and body mass index, SpO<sub>2,</sub> and heart rate (<i>P</i> > 0.05). From 15 min after the start of surgery to 6 h postoperatively, the mean arterial pressure in the dexmedetomidine group was significantly lower than that in the other three groups, including ketamine, etomidate, and control (<i>P</i> < 0.05). The mean sedation score (Ramsay) during recovery and 1 h postoperatively was higher in the dexmedetomidine group compared with that in the control group, whereas the recovery time in the dexmedetomidine group was higher than that in the other groups (<i>P</i> < 0.001). In addition, the amount of propofol consumption in the two groups of dexmedetomidine and ketamine was significantly less than that in the etomidate and control groups (<i>P</i> < 0.001).</p><p><strong>Conclusions: </strong>According to the results, dexmedetomidine caused better hemodynamic changes with more reduction in blood pressure and heart rate, and patients in the dexmedetomidine group did not require any specific medical treatment. Moreover, higher patient satisfaction and longer recovery duration were observed in the dexmedetomidine group than in the other study groups. As such, it is suggested that dexmedetomidine be used as an adjuvant in cataract surgery for more sedation, analgesia, and optimal intraoperative conditions.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/91/47/JCO-34-414.PMC10170987.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9469876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Malignant Glaucoma. 恶性青光眼的治疗。
IF 1.5 Q2 Medicine Pub Date : 2022-10-01 DOI: 10.4103/joco.joco_147_22
Reza Sadeghi, Ali Momeni, Ghasem Fakhraie, Yadollah Eslami, Reza Zarei, Zakieh Vahedian, Mona Safizadeh, Seyed Mehdi Tabatabaei

Purpose: To compare the outcomes of various invasive and noninvasive approaches to the treatment of malignant glaucoma.

Methods: Glaucoma-related keywords were looked up in PubMed and Google Scholar, and related articles up to 2022 were used to put together this review article.

Results: Numerous surgical methods and techniques have been introduced in the past few years. This review outlined current knowledge regarding the nonsurgical and surgical management of malignant glaucoma. In this regard, we first briefly outlined the clinical presentation, pathophysiology, and diagnosis of this disorder. Then, the current evidence on the management of malignant glaucoma was reviewed. Finally, we discuss the need for treatment of the other eye and the factors that might affect the outcome of surgical intervention.

Conclusions: Fluid misdirection syndrome, or malignant glaucoma, is a severe disorder that can occur spontaneously due to surgical intervention. The pathophysiology of malignant glaucoma is complicated, and numerous theories exist about the underlying mechanisms that may contribute to the disease. Malignant glaucoma can be treated conservatively using medications, laser therapy, or surgery. Laser treatments and medical treatments have been adequate for the treatment of glaucoma, but the effects have generally been short-lived, and surgical treatment has proved to be the most effective. There have been a variety of surgical methods and techniques introduced. Still, none have been studied in a large proportion of patients as a control case to compare effectiveness, outcomes, and recurrence. Pars plana vitrectomy with irido-zonulo-capsulectomy still seems to have the best results.

目的:比较各种有创与无创方法治疗恶性青光眼的疗效。方法:在PubMed和Google Scholar中检索青光眼相关关键词,使用截至2022年的相关文章进行汇总。结果:近年来引进了多种手术方法和技术。这篇综述概述了目前关于非手术和手术治疗恶性青光眼的知识。在这方面,我们首先简要概述了临床表现,病理生理和诊断这种疾病。然后,对目前恶性青光眼的治疗进行了综述。最后,我们讨论了治疗另一只眼的必要性和可能影响手术干预结果的因素。结论:液体误导综合征或恶性青光眼是一种严重的疾病,可因手术干预而自发发生。恶性青光眼的病理生理是复杂的,关于其发病机制存在多种理论。恶性青光眼可以使用药物、激光疗法或手术保守治疗。激光治疗和药物治疗已经足够治疗青光眼,但效果通常是短暂的,手术治疗已被证明是最有效的。已经介绍了各种各样的手术方法和技术。尽管如此,还没有研究在大比例的患者中作为对照病例来比较有效性,结果和复发率。睫状体部玻璃体切除术联合虹膜带囊切除术似乎仍有最好的效果。
{"title":"Management of Malignant Glaucoma.","authors":"Reza Sadeghi,&nbsp;Ali Momeni,&nbsp;Ghasem Fakhraie,&nbsp;Yadollah Eslami,&nbsp;Reza Zarei,&nbsp;Zakieh Vahedian,&nbsp;Mona Safizadeh,&nbsp;Seyed Mehdi Tabatabaei","doi":"10.4103/joco.joco_147_22","DOIUrl":"https://doi.org/10.4103/joco.joco_147_22","url":null,"abstract":"<p><strong>Purpose: </strong>To compare the outcomes of various invasive and noninvasive approaches to the treatment of malignant glaucoma.</p><p><strong>Methods: </strong>Glaucoma-related keywords were looked up in PubMed and Google Scholar, and related articles up to 2022 were used to put together this review article.</p><p><strong>Results: </strong>Numerous surgical methods and techniques have been introduced in the past few years. This review outlined current knowledge regarding the nonsurgical and surgical management of malignant glaucoma. In this regard, we first briefly outlined the clinical presentation, pathophysiology, and diagnosis of this disorder. Then, the current evidence on the management of malignant glaucoma was reviewed. Finally, we discuss the need for treatment of the other eye and the factors that might affect the outcome of surgical intervention.</p><p><strong>Conclusions: </strong>Fluid misdirection syndrome, or malignant glaucoma, is a severe disorder that can occur spontaneously due to surgical intervention. The pathophysiology of malignant glaucoma is complicated, and numerous theories exist about the underlying mechanisms that may contribute to the disease. Malignant glaucoma can be treated conservatively using medications, laser therapy, or surgery. Laser treatments and medical treatments have been adequate for the treatment of glaucoma, but the effects have generally been short-lived, and surgical treatment has proved to be the most effective. There have been a variety of surgical methods and techniques introduced. Still, none have been studied in a large proportion of patients as a control case to compare effectiveness, outcomes, and recurrence. Pars plana vitrectomy with irido-zonulo-capsulectomy still seems to have the best results.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/65/8a/JCO-34-389.PMC10170992.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9822299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Coronavirus Disease 2019 Pandemic on the Epidemiology of Intravitreal Injections. 2019冠状病毒病大流行对玻璃体内注射流行病学的影响
IF 1.5 Q2 Medicine Pub Date : 2022-10-01 DOI: 10.4103/joco.joco_253_22
Masoud Mirghorbani, Hamid Riazi-Esfahani, Fatemeh Bazvand, Mohammadreza Mehrabi Bahar, Mehdi Yaseri, Mohammad Zarei

Purpose: To evaluate the epidemiologic pattern of intravitreal injections (IVIs) during Coronavirus Disease 2019 (COVID-19) pandemic.

Methods: The records of patients receiving IVIs in two 12-month periods immediately before and after the beginning of the COVID-19 epidemic were included. Age, province of residency, indication, number of injections, and number of operating room (OR) visits were analyzed.

Results: Compared to pre-COVID period, a 37.6% decrease in the number of patients receiving IVI in COVID period was seen (10518 vs. 6569). There was a parallel decrease in the number of OR visits (25590 vs. 15010: 41.4%) and injections (34508 vs. 19879: 42.4%). Regarding IVI indication, age-related macular degeneration (AMD) showed the highest decrease in IVI rate (46.3%) which was significantly higher than decrease in other indications (P < 0.001). Retinopathy of prematurity (ROP) patients showed no change after epidemic. Mean overall age in AMD group was the highest (67.7 ± 13.2 years) compared to other indication groups (excluding ROP) (P < 0.001); while the mean age of the other indications was not significantly different from each other (excluding ROP).

Conclusions: COVID pandemic decreased the number of IVIs significantly. While previous studies suggested that the AMD patients had the highest risk of visual loss due to failure to receive IVIs in a timely manner, this very same group showed the highest decrease in the IVI number after pandemic. The health systems should devise strategies to protect this most vulnerable group of patients in future similar crises.

目的:探讨2019冠状病毒病(COVID-19)大流行期间玻璃体内注射(IVIs)的流行病学特征。方法:收集COVID-19疫情开始前后两个12个月内接受静脉注射的患者记录。分析年龄、居住省份、适应证、注射次数和手术室就诊次数。结果:与COVID前相比,COVID期间接受IVI的患者数量减少了37.6%(10518例对6569例)。手术室就诊次数(25590次vs. 15010次:41.4%)和注射次数(34508次vs. 19879次:42.4%)也有平行下降。在IVI适应症中,年龄相关性黄斑变性(AMD)的IVI率下降幅度最大(46.3%),显著高于其他适应症的下降幅度(P < 0.001)。早产儿视网膜病变(ROP)流行后无明显变化。AMD组患者平均总年龄(67.7±13.2岁)高于其他适应症组(不含ROP) (P < 0.001);而其他适应症的平均年龄差异无统计学意义(不包括ROP)。结论:新冠肺炎疫情显著降低了静脉注射次数。虽然先前的研究表明,由于未能及时接受静脉注射,AMD患者视力丧失的风险最高,但同一组在大流行后静脉注射数量下降幅度最大。卫生系统应制定战略,在未来类似危机中保护这一最脆弱的患者群体。
{"title":"Impact of Coronavirus Disease 2019 Pandemic on the Epidemiology of Intravitreal Injections.","authors":"Masoud Mirghorbani,&nbsp;Hamid Riazi-Esfahani,&nbsp;Fatemeh Bazvand,&nbsp;Mohammadreza Mehrabi Bahar,&nbsp;Mehdi Yaseri,&nbsp;Mohammad Zarei","doi":"10.4103/joco.joco_253_22","DOIUrl":"https://doi.org/10.4103/joco.joco_253_22","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the epidemiologic pattern of intravitreal injections (IVIs) during Coronavirus Disease 2019 (COVID-19) pandemic.</p><p><strong>Methods: </strong>The records of patients receiving IVIs in two 12-month periods immediately before and after the beginning of the COVID-19 epidemic were included. Age, province of residency, indication, number of injections, and number of operating room (OR) visits were analyzed.</p><p><strong>Results: </strong>Compared to pre-COVID period, a 37.6% decrease in the number of patients receiving IVI in COVID period was seen (10518 vs. 6569). There was a parallel decrease in the number of OR visits (25590 vs. 15010: 41.4%) and injections (34508 vs. 19879: 42.4%). Regarding IVI indication, age-related macular degeneration (AMD) showed the highest decrease in IVI rate (46.3%) which was significantly higher than decrease in other indications (<i>P</i> < 0.001). Retinopathy of prematurity (ROP) patients showed no change after epidemic. Mean overall age in AMD group was the highest (67.7 ± 13.2 years) compared to other indication groups (excluding ROP) (<i>P</i> < 0.001); while the mean age of the other indications was not significantly different from each other (excluding ROP).</p><p><strong>Conclusions: </strong>COVID pandemic decreased the number of IVIs significantly. While previous studies suggested that the AMD patients had the highest risk of visual loss due to failure to receive IVIs in a timely manner, this very same group showed the highest decrease in the IVI number after pandemic. The health systems should devise strategies to protect this most vulnerable group of patients in future similar crises.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7a/8c/JCO-34-442.PMC10170993.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9523136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is Type 2 Macular Telangiectasia a Bilateral and Symmetrical Disease Entity? 2型黄斑毛细血管扩张是一种双侧对称疾病吗?
IF 1.5 Q2 Medicine Pub Date : 2022-10-01 DOI: 10.4103/joco.joco_68_22
Ramesh Venkatesh, Harshita Nahata, Nikitha Gurram Reddy, Pranjal Mishra, Rubble Mangla, Naresh Kumar Yadav, Jay Chhablani

Purpose: To study the inter-eye asymmetry in cases diagnosed with type 2 macular telangiectasia (MacTel).

Methods: Herein, type 2 MacTel cases were staged as per Gass and Blodi classification with multiple imaging techniques. Based on disease stage symmetry, two groups identified. Group 1: Symmetrical stage and Group 2: Asymmetrical stage MacTel disease. Prevalence, demography, and clinical features of MacTel cases showing inter-eye asymmetry were analyzed.

Results: Two hundred and eighty eyes of 140 patients diagnosed clinically with type 2 MacTel (84-Group 1 and 56-Group 2) were evaluated. Eighty-nine (64%) were female, and the median age of the entire cohort was 62.5 years (inter-quartile range: 57.0-68.75). MacTel disease with asymmetric stage was seen in 56 (40%) of the 140 patients. At presentation, a two-stage difference was noted in 46% (n = 26) of the patients with asymmetrical MacTel disease. A 10% conversion from symmetrical to asymmetrical disease stage was noted at the final visit. Of the 280 eyes evaluated for type 2 MacTel disease, 12 (4%) eyes showed no findings suggestive of MacTel on clinical examination and fluorescein angiography, optical coherence tomography (OCT), and OCT angiography when available and were labeled as unilateral type 2 MacTel disease.

Conclusions: Type 2 MacTel can show inter-eye disease stage asymmetry. Unilateral type 2 MacTel disease is a distinct stage in MacTel which would need further evaluation and consideration while staging.

目的:探讨2型黄斑毛细血管扩张(MacTel)患者的眼间不对称性。方法:2型MacTel病例采用多种影像学技术,按Gass和Blodi分型进行分期。基于疾病阶段的对称性,两组确定。组1:对称期;组2:不对称期。分析MacTel病例眼间不对称的患病率、人口学和临床特征。结果:140例临床诊断为2型MacTel的患者共280只眼(1组84只,2组56只)。89例(64%)为女性,整个队列的中位年龄为62.5岁(四分位数间距:57.0-68.75)。140例患者中有56例(40%)出现不对称期MacTel病。在46% (n = 26)的不对称MacTel病患者中,出现了两期差异。在最后一次访问时,注意到从对称到不对称的疾病阶段有10%的转换。在280只被评估为2型MacTel病的眼睛中,12只(4%)的眼睛在临床检查、荧光素血管造影、光学相干断层扫描(OCT)和OCT血管造影(如果有的话)中没有显示MacTel的症状,并被标记为单侧2型MacTel病。结论:2型MacTel可显示眼间疾病分期不对称。单侧2型MacTel疾病是MacTel的一个不同阶段,在分期时需要进一步评估和考虑。
{"title":"Is Type 2 Macular Telangiectasia a Bilateral and Symmetrical Disease Entity?","authors":"Ramesh Venkatesh,&nbsp;Harshita Nahata,&nbsp;Nikitha Gurram Reddy,&nbsp;Pranjal Mishra,&nbsp;Rubble Mangla,&nbsp;Naresh Kumar Yadav,&nbsp;Jay Chhablani","doi":"10.4103/joco.joco_68_22","DOIUrl":"https://doi.org/10.4103/joco.joco_68_22","url":null,"abstract":"<p><strong>Purpose: </strong>To study the inter-eye asymmetry in cases diagnosed with type 2 macular telangiectasia (MacTel).</p><p><strong>Methods: </strong>Herein, type 2 MacTel cases were staged as per Gass and Blodi classification with multiple imaging techniques. Based on disease stage symmetry, two groups identified. Group 1: Symmetrical stage and Group 2: Asymmetrical stage MacTel disease. Prevalence, demography, and clinical features of MacTel cases showing inter-eye asymmetry were analyzed.</p><p><strong>Results: </strong>Two hundred and eighty eyes of 140 patients diagnosed clinically with type 2 MacTel (84-Group 1 and 56-Group 2) were evaluated. Eighty-nine (64%) were female, and the median age of the entire cohort was 62.5 years (inter-quartile range: 57.0-68.75). MacTel disease with asymmetric stage was seen in 56 (40%) of the 140 patients. At presentation, a two-stage difference was noted in 46% (<i>n</i> = 26) of the patients with asymmetrical MacTel disease. A 10% conversion from symmetrical to asymmetrical disease stage was noted at the final visit. Of the 280 eyes evaluated for type 2 MacTel disease, 12 (4%) eyes showed no findings suggestive of MacTel on clinical examination and fluorescein angiography, optical coherence tomography (OCT), and OCT angiography when available and were labeled as unilateral type 2 MacTel disease.</p><p><strong>Conclusions: </strong>Type 2 MacTel can show inter-eye disease stage asymmetry. Unilateral type 2 MacTel disease is a distinct stage in MacTel which would need further evaluation and consideration while staging.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b5/7f/JCO-34-428.PMC10170975.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9469875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Association of Risk Factors among Nasal and Orbital Mucormycosis in Coronavirus Disease 2019 Infection: A Cross-Sectional Study. 冠状病毒病2019感染中鼻和眶毛霉菌病危险因素的相关性:一项横断面研究
IF 1.5 Q2 Medicine Pub Date : 2022-10-01 DOI: 10.4103/joco.joco_78_22
Ramasamy Vidhyadevi, S Saudhamini, Sundaram Padmanaban, Devisundaram Sundar, Suvetha Kannappan, Gopalsamy Suryaprabha

Purpose: To study the risk factors of mucormycosis and analyze their association among nasal and orbital mucormycosis in Coronavirus disease 2019 (COVID-19) infection.

Methods: All patients diagnosed of rhino-orbito-cerebral mucormycosis (ROCM) with previous COVID-19 infection were included in the study. The details such as age, sex, presence of co-morbidities, and serum ferritin levels were collected. ROCM patients were classified into two groups, nasal mucormycosis (stage 1 and 2 of ROCM) and orbital mucormycosis (stage 3 and 4 of ROCM), and data were collected. Duration of COVID-19 symptoms, the time interval between COVID-19 infection and onset of ROCM symptoms, computed tomography severity score (CTSS) and usage of steroids were collected accordingly. The collected data were compared between nasal group and orbital group.

Results: Among 52 patients, 15 patients had nasal and 37 patients had orbital mucormycosis. Forty-one patients were more than 40 years, 43 patients were males. Seven out of ten risk factors were found to be significant on comparing nasal and orbital group. Patients of age more than 40 years (P = 0.034), elderly diabetics (P = 0.014), poor control of diabetes (P = 0.003), high serum ferritin levels (P = 0.043), duration between COVID-19 and mucormycosis of more than 20 days (P = 0.038), CTSS of more than 9/25 (P = 0.020), and steroid usage during COVID-19 infection (P = 0.034) are prone to develop orbital mucormycosis. On multivariate logistic regression analysis, these variables did not emerge as independent risk factors.

Conclusions: Patients with severe COVID-19 infection along with other associated risk factors can be prone to develop severe forms of mucormycosis. We did not find them to be statistically significant on multivariate analysis. In the future, large scale studies are needed to know their significance.

目的:探讨鼻粘膜真菌病的危险因素,分析鼻、眶粘膜真菌病与2019冠状病毒病(COVID-19)感染的关系。方法:纳入所有诊断为鼻-眶-脑毛霉菌病(ROCM)且既往感染COVID-19的患者。收集了年龄、性别、合并症的存在和血清铁蛋白水平等细节。将ROCM患者分为鼻毛霉菌病(ROCM的1期和2期)和眶毛霉菌病(ROCM的3期和4期)两组,并收集数据。收集患者COVID-19症状持续时间、COVID-19感染至出现ROCM症状的时间间隔、计算机断层扫描严重程度评分(CTSS)和类固醇使用情况。将鼻组与眶组的数据进行比较。结果:52例患者中鼻毛霉病15例,眶毛霉病37例。40岁以上41例,男性43例。10个危险因素中有7个是显著的。年龄大于40岁(P = 0.034)、老年糖尿病(P = 0.014)、糖尿病控制不良(P = 0.003)、血清铁蛋白水平高(P = 0.043)、COVID-19与毛霉菌病病程间隔大于20天(P = 0.038)、CTSS大于9/25 (P = 0.020)、感染期间使用类固醇(P = 0.034)的患者易发生眼眶毛霉菌病。在多元逻辑回归分析中,这些变量并没有成为独立的危险因素。结论:伴有其他相关危险因素的严重COVID-19感染患者可能容易发展为严重形式的毛霉病。在多变量分析中,我们没有发现它们具有统计学显著性。在未来,需要大规模的研究来了解其意义。
{"title":"Association of Risk Factors among Nasal and Orbital Mucormycosis in Coronavirus Disease 2019 Infection: A Cross-Sectional Study.","authors":"Ramasamy Vidhyadevi,&nbsp;S Saudhamini,&nbsp;Sundaram Padmanaban,&nbsp;Devisundaram Sundar,&nbsp;Suvetha Kannappan,&nbsp;Gopalsamy Suryaprabha","doi":"10.4103/joco.joco_78_22","DOIUrl":"https://doi.org/10.4103/joco.joco_78_22","url":null,"abstract":"<p><strong>Purpose: </strong>To study the risk factors of mucormycosis and analyze their association among nasal and orbital mucormycosis in Coronavirus disease 2019 (COVID-19) infection.</p><p><strong>Methods: </strong>All patients diagnosed of rhino-orbito-cerebral mucormycosis (ROCM) with previous COVID-19 infection were included in the study. The details such as age, sex, presence of co-morbidities, and serum ferritin levels were collected. ROCM patients were classified into two groups, nasal mucormycosis (stage 1 and 2 of ROCM) and orbital mucormycosis (stage 3 and 4 of ROCM), and data were collected. Duration of COVID-19 symptoms, the time interval between COVID-19 infection and onset of ROCM symptoms, computed tomography severity score (CTSS) and usage of steroids were collected accordingly. The collected data were compared between nasal group and orbital group.</p><p><strong>Results: </strong>Among 52 patients, 15 patients had nasal and 37 patients had orbital mucormycosis. Forty-one patients were more than 40 years, 43 patients were males. Seven out of ten risk factors were found to be significant on comparing nasal and orbital group. Patients of age more than 40 years (<i>P</i> = 0.034), elderly diabetics (<i>P</i> = 0.014), poor control of diabetes (<i>P</i> = 0.003), high serum ferritin levels (<i>P</i> = 0.043), duration between COVID-19 and mucormycosis of more than 20 days (<i>P</i> = 0.038), CTSS of more than 9/25 (<i>P</i> = 0.020), and steroid usage during COVID-19 infection (<i>P</i> = 0.034) are prone to develop orbital mucormycosis. On multivariate logistic regression analysis, these variables did not emerge as independent risk factors.</p><p><strong>Conclusions: </strong>Patients with severe COVID-19 infection along with other associated risk factors can be prone to develop severe forms of mucormycosis. We did not find them to be statistically significant on multivariate analysis. In the future, large scale studies are needed to know their significance.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/98/97/JCO-34-460.PMC10170986.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9472964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medial Rectus Plication in the Management of Dissociated Horizontal Deviation: Case Report and Literature Review. 内侧直肌伸展术治疗游离性水平偏移:病例报告及文献回顾。
IF 1.5 Q2 Medicine Pub Date : 2022-10-01 DOI: 10.4103/joco.joco_6_22
Mohammad Yaser Kiarudi, Bahar Tafaghodi, Aliakbar Sabermoghadm, Acieh Es'haghi, Seyed Hosein Ghavami Shahri

Purpose: To report a case of medial rectus plication for the management of dissociated horizontal deviation (DHD).

Methods: We introduce medial rectus plication for improving the control of exoshift of DHD.

Results: A 20-year-old woman with a chief complaint of left eye outward deviation since childhood was referred to the strabismus clinic. The diagnosis of DHD was made according to the detection of asymmetric slow abduction of the left eye (50 prism diopter) during visual inattention or cover testing. The left lateral rectus (LR) was recessed 8 mm with a posterior fixation suture (PFS). In the early postoperative period, the control of DHD improved; however, after 6 months, the patient and her parents complained of frequent observation of the exoshift of the left eye (30 prism diopter). For better control of DHD, medial rectus plication (5 mm) of the left eye was considered the second operation. After 12 months of follow-up, the control of deviation improved, and there was no manifest deviation.

Conclusions: The literature's recommended procedure for unilateral DHD without a duction deficit is to perform a unilateral LR muscle recession. Some authors have proposed adding PFS to augment the effect of LR recessions. Although recurrence may occur, medial rectus plication can be considered one of the reversible options and can be used in recurrences of DHD after the first surgical procedure.

目的:报告一例内直肌复制术治疗游离性水平偏差(DHD)。方法:采用内直肌伸展术改善对DHD外移的控制。结果:一名20岁女性,自幼以左眼向外偏为主诉,在斜视门诊就诊。根据视觉不注意或盖检时左眼(50棱镜屈光度)不对称缓慢外展进行诊断。用后路固定缝线(PFS)将左外侧直肌(LR)内凹8mm。术后早期,DHD的控制有所改善;然而,6个月后,患者及其父母抱怨经常观察到左眼外移(30棱镜屈光度)。为了更好地控制DHD,考虑第二次手术左眼内侧直肌皱襞(5mm)。随访12个月,偏差控制改善,无明显偏差。结论:文献推荐的治疗无内陷缺陷的单侧DHD的方法是行单侧左腹肌退缩术。一些作者建议增加PFS以增强LR衰退的影响。虽然可能会发生复发,但内侧直肌复制术可被认为是可逆的选择之一,可用于首次手术后的DHD复发。
{"title":"Medial Rectus Plication in the Management of Dissociated Horizontal Deviation: Case Report and Literature Review.","authors":"Mohammad Yaser Kiarudi,&nbsp;Bahar Tafaghodi,&nbsp;Aliakbar Sabermoghadm,&nbsp;Acieh Es'haghi,&nbsp;Seyed Hosein Ghavami Shahri","doi":"10.4103/joco.joco_6_22","DOIUrl":"https://doi.org/10.4103/joco.joco_6_22","url":null,"abstract":"<p><strong>Purpose: </strong>To report a case of medial rectus plication for the management of dissociated horizontal deviation (DHD).</p><p><strong>Methods: </strong>We introduce medial rectus plication for improving the control of exoshift of DHD.</p><p><strong>Results: </strong>A 20-year-old woman with a chief complaint of left eye outward deviation since childhood was referred to the strabismus clinic. The diagnosis of DHD was made according to the detection of asymmetric slow abduction of the left eye (50 prism diopter) during visual inattention or cover testing. The left lateral rectus (LR) was recessed 8 mm with a posterior fixation suture (PFS). In the early postoperative period, the control of DHD improved; however, after 6 months, the patient and her parents complained of frequent observation of the exoshift of the left eye (30 prism diopter). For better control of DHD, medial rectus plication (5 mm) of the left eye was considered the second operation. After 12 months of follow-up, the control of deviation improved, and there was no manifest deviation.</p><p><strong>Conclusions: </strong>The literature's recommended procedure for unilateral DHD without a duction deficit is to perform a unilateral LR muscle recession. Some authors have proposed adding PFS to augment the effect of LR recessions. Although recurrence may occur, medial rectus plication can be considered one of the reversible options and can be used in recurrences of DHD after the first surgical procedure.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c5/3e/JCO-34-483.PMC10170982.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9469874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk Factors for Uncorrected Refractive Error: Persian Cohort Eye Study - Rafsanjan Center. 未矫正屈光不正的危险因素:波斯队列眼研究-拉夫桑詹中心。
IF 1.5 Q2 Medicine Pub Date : 2022-10-01 DOI: 10.4103/joco.joco_160_22
Mohammadreza Soleimani, Bahar Saberzadeh-Ardestani, Hamid Hakimi, Akbar Fotouhi, Fateme Alipour, Fatemeh Jafari, Alireza Lashay, Hassan Hashemi

Purpose: To determine the prevalence of visually significant uncorrected refractive error (URE) in Rafsanjan and investigate the related factors. URE is the leading cause of visual impairment (VI) which causes the second-highest number of years lived with disability. The URE is a preventable health problem.

Methods: In this cross-sectional study participants from Rafsanjan who were 35-70 years were enrolled between 2014 and 2020. Demographic and clinical characteristics data were gathered, and eye examination was performed. Visually significant URE was defined as present if habitual visual acuity was (HVA; visual acuity with present optical correction) >0.3 logMAR in the best eye and the visual acuity of that eye showed >0.2 logMAR improvement after the best correction. Logistic regression was used to determine the association between predicting variables (age, sex, wealth, education, employment, diabetes, cataract, and refractive error characteristics) and outcome (URE).

Results: Among the 6991 participants of Rafsanjan subcohort of the Persian Eye Cohort, 311 (4.4%) had a visually significant URE. Diabetes was significantly more prevalent in the participants with visually significant URE, at 18.7% versus 13.1% in patients without significant URE (P = 0.004). In the final model, each year of increase in age was associated with 3% higher URE (95% confidence interval [CI]: 1.01-1.05). In comparison to low hyperopia, participants with low myopia had 5.17 times more odds of visually significant URE (95% CI: 3.38-7.93). However, antimetropia decreased the risk of visually significant URE (95% CI: 0.02-0.37).

Conclusion: Policymakers should pay special attention to elderly patients with myopia to effectively reduce the prevalence of visually significant URE.

目的:了解拉夫桑詹地区明显未矫正屈光不正(URE)的发生率,并探讨相关因素。URE是导致视力损害(VI)的主要原因,导致残疾生活年数第二高。尿失禁是一种可预防的健康问题。方法:在这项横断面研究中,来自拉夫桑詹的35-70岁的参与者在2014年至2020年期间入组。收集人口统计学和临床特征资料,并进行眼科检查。如果习惯性视力为(HVA;最佳眼视力改善>0.3 logMAR,最佳眼视力改善>0.2 logMAR。使用逻辑回归来确定预测变量(年龄、性别、财富、教育、就业、糖尿病、白内障和屈光不正特征)与结果(URE)之间的关联。结果:在波斯眼队列的Rafsanjan亚队列的6991名参与者中,311名(4.4%)有明显的URE。糖尿病在视觉上显著性URE患者中更为普遍,为18.7%,而在无显著性URE患者中为13.1% (P = 0.004)。在最后的模型中,年龄每增加一年,URE增加3%(95%置信区间[CI]: 1.01-1.05)。与低远视相比,低近视眼的参与者有5.17倍的视觉显著性URE的几率(95% CI: 3.38-7.93)。然而,屈光不正降低了显著性URE的风险(95% CI: 0.02-0.37)。结论:决策者应特别关注老年近视患者,以有效降低视力显著性URE的患病率。
{"title":"Risk Factors for Uncorrected Refractive Error: Persian Cohort Eye Study - Rafsanjan Center.","authors":"Mohammadreza Soleimani,&nbsp;Bahar Saberzadeh-Ardestani,&nbsp;Hamid Hakimi,&nbsp;Akbar Fotouhi,&nbsp;Fateme Alipour,&nbsp;Fatemeh Jafari,&nbsp;Alireza Lashay,&nbsp;Hassan Hashemi","doi":"10.4103/joco.joco_160_22","DOIUrl":"https://doi.org/10.4103/joco.joco_160_22","url":null,"abstract":"<p><strong>Purpose: </strong>To determine the prevalence of visually significant uncorrected refractive error (URE) in Rafsanjan and investigate the related factors. URE is the leading cause of visual impairment (VI) which causes the second-highest number of years lived with disability. The URE is a preventable health problem.</p><p><strong>Methods: </strong>In this cross-sectional study participants from Rafsanjan who were 35-70 years were enrolled between 2014 and 2020. Demographic and clinical characteristics data were gathered, and eye examination was performed. Visually significant URE was defined as present if habitual visual acuity was (HVA; visual acuity with present optical correction) >0.3 logMAR in the best eye and the visual acuity of that eye showed >0.2 logMAR improvement after the best correction. Logistic regression was used to determine the association between predicting variables (age, sex, wealth, education, employment, diabetes, cataract, and refractive error characteristics) and outcome (URE).</p><p><strong>Results: </strong>Among the 6991 participants of Rafsanjan subcohort of the Persian Eye Cohort, 311 (4.4%) had a visually significant URE. Diabetes was significantly more prevalent in the participants with visually significant URE, at 18.7% versus 13.1% in patients without significant URE (<i>P</i> = 0.004). In the final model, each year of increase in age was associated with 3% higher URE (95% confidence interval [CI]: 1.01-1.05). In comparison to low hyperopia, participants with low myopia had 5.17 times more odds of visually significant URE (95% CI: 3.38-7.93). However, antimetropia decreased the risk of visually significant URE (95% CI: 0.02-0.37).</p><p><strong>Conclusion: </strong>Policymakers should pay special attention to elderly patients with myopia to effectively reduce the prevalence of visually significant URE.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/07/a4/JCO-34-421.PMC10170991.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9469878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lacrimal Canalicular Bypass Surgery with Autologous Superficial Temporal Artery Graft. 自体颞浅动脉移植泪小管搭桥手术。
IF 1.5 Q2 Medicine Pub Date : 2022-10-01 DOI: 10.4103/joco.joco_98_22
Mansooreh Jamshidian-Tehrani, Mohsen Bahmani Kashkouli, Hossein Ghahvehchian, Mohammad Amini

Purpose: To describe superficial temporal artery graft as a new autologous tissue to reconstruct the upper lacrimal drainage system.

Methods: We explain the history of a 30-year-old female with upper lacrimal drainage system obstruction, in whom conjunctivodacryocystorhinostomy (CDCR) failed to resolve epiphora. A superficial temporal artery graft was harvested, intubated with Masterka tube, and implanted between the conjunctiva and nasal cavity. Masterka was replaced with a thicker dummy tube 12 weeks postoperatively. The adequacy of the graft was checked with irrigation tests in follow-up visits from 1 to 26 months after the procedure.

Results: Superficial temporal artery autograft successfully eliminated epiphora of the patient in whom (CDCR) with Jones tube failed to make her symptom free.

Conclusion: Superficial temporal artery autograft as an autogenous tissue with adequate characteristics can be considered in selective patients of upper lacrimal obstruction to reconstruct the lacrimal drainage system.

目的:介绍一种新的自体颞浅动脉移植重建上泪道引流系统的方法。方法:我们分析了一位30岁女性上泪道引流系统梗阻,结膜泪囊鼻腔造瘘术(CDCR)未能解决泪溢的病史。取颞浅动脉移植物,用Masterka管插管,植入结膜和鼻腔之间。术后12周更换Masterka假管。在术后1至26个月的随访中,用冲洗试验检查移植物的充分性。结果:自体颞浅动脉移植物成功地消除了琼斯管CDCR未能使症状消失的患者的上显。结论:颞浅动脉自体移植物作为一种具有良好特性的自体组织,在选择性泪道梗阻患者中可考虑重建泪道引流系统。
{"title":"Lacrimal Canalicular Bypass Surgery with Autologous Superficial Temporal Artery Graft.","authors":"Mansooreh Jamshidian-Tehrani,&nbsp;Mohsen Bahmani Kashkouli,&nbsp;Hossein Ghahvehchian,&nbsp;Mohammad Amini","doi":"10.4103/joco.joco_98_22","DOIUrl":"https://doi.org/10.4103/joco.joco_98_22","url":null,"abstract":"<p><strong>Purpose: </strong>To describe superficial temporal artery graft as a new autologous tissue to reconstruct the upper lacrimal drainage system.</p><p><strong>Methods: </strong>We explain the history of a 30-year-old female with upper lacrimal drainage system obstruction, in whom conjunctivodacryocystorhinostomy (CDCR) failed to resolve epiphora. A superficial temporal artery graft was harvested, intubated with Masterka tube, and implanted between the conjunctiva and nasal cavity. Masterka was replaced with a thicker dummy tube 12 weeks postoperatively. The adequacy of the graft was checked with irrigation tests in follow-up visits from 1 to 26 months after the procedure.</p><p><strong>Results: </strong>Superficial temporal artery autograft successfully eliminated epiphora of the patient in whom (CDCR) with Jones tube failed to make her symptom free.</p><p><strong>Conclusion: </strong>Superficial temporal artery autograft as an autogenous tissue with adequate characteristics can be considered in selective patients of upper lacrimal obstruction to reconstruct the lacrimal drainage system.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5a/36/JCO-34-486.PMC10170988.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9523137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Current Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1